Comparison of relative changes in phosphatic metabolites and phospholipids after irradiation.

Measurements of phosphatic metabolites and phospholipids using 31P NMR spectroscopy were performed on tumor extracts at specific times before and after a priming dose of radiation at 32 or 65 Gy. At both doses, statistically significant increases in the high-energy phosphates PCr and ATP, relative to their primary hydrolysis product Pi, were detected at 24 h after irradiation. These spectral changes are consistent with an increased capacity for aerobic metabolism and oxidative phosphorylation. The changes coincide with a significant reduction in the hypoxic cell fraction and 50% tumor control dose measurements reported previously for the same tumor model. A significant increase in the ratio of phosphorylethanolamine to phosphorylcholine was also detected at 24 h. The ratio of ethanolamine-containing to choline-containing phospholipids increased significantly between 48 and 96 h. The spectral changes measured in this study coincide with the changes in the hypoxic state of the tumor after irradiation and are consistent with spectral measurements performed in vivo. The high-resolution spectroscopic data also identify specific metabolites contributing to spectral changes measured in vivo.

[1]  T. Merchant,et al.  Quantitative changes in tumor metabolism, partial pressure of oxygen, and radiobiological oxygenation status postradiation. , 1992, Cancer research.

[2]  J. Moulder,et al.  Effects of local irradiation on spin‐lattice relaxation time of phosphate metabolites in mouse tumors monitored by 31P magnetic resonance spectroscopy , 1992, Magnetic resonance in medicine.

[3]  H C Charles,et al.  Evaluation of ba1112 rhabdomyosarcoma oxygenation with microelectrodes, optical spectrophotometry, radiosensitivity, and magnetic resonance spectroscopy , 1991, Magnetic resonance in medicine.

[4]  J. Pettegrew,et al.  L‐Phosphoserine, a Metabolite Elevated in Alzheimer's Disease, Interacts with Specific L‐Glutamate Receptor Subtypes , 1991, Journal of Neurochemistry.

[5]  T. Merchant,et al.  31P magnetic resonance phospholipid profiles of neoplastic human breast tissues. , 1991, British Journal of Cancer.

[6]  T. Ng,et al.  Phosphorus metabolites and the distribution of cell cycle phase of RIF‐1 tumors in response to 14 Gy irradiation , 1990, Magnetic Resonance in Medicine.

[7]  D. Ballon,et al.  Changes in radiation sensitization induced by Fluosol-DA as measured by 31P nuclear magnetic resonance spectroscopy. , 1990, Cancer research.

[8]  T. Merchant,et al.  31P NMR of phospholipid glycerol phosphodiester residues. , 1990, Journal of lipid research.

[9]  J. Pettegrew,et al.  31P NMR of Brain Aging and Alzheimer’s Disease , 1990 .

[10]  P Okunieff,et al.  Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma. , 1989, Radiation research.

[11]  R. Steen,et al.  31P NMR spectroscopic study of bioenergetic changes in radiation‐induced fibrosarcoma‐1 after radiation therapy , 1989, NMR in biomedicine.

[12]  J. Koutcher,et al.  Relationship between energy status, hypoxic cell fraction, and hyperthermic sensitivity in a murine fibrosarcoma. , 1989, Radiation research.

[13]  J R Griffiths,et al.  Phosphorus-31 magnetic resonance spectroscopy and blood perfusion of the RIF-1 tumor following X-irradiation. , 1989, International journal of radiation oncology, biology, physics.

[14]  J. Pettegrew,et al.  31P Nuclear Magnetic Resonance Study of the Brain in Alzheimer's Disease , 1988, Journal of neuropathology and experimental neurology.

[15]  T. Glonek,et al.  High resolution 31P NMR of extracted phospholipids. , 1988, Journal of lipid research.

[16]  P. Okunieff,et al.  Size dependent changes in tumor phosphate metabolism after radiation therapy as detected by 31P NMR spectroscopy. , 1987, International journal of radiation oncology, biology, physics.

[17]  P. Okunieff,et al.  Effects of Oxygen on the Metabolism of Murine Tumors Using in Vivo Phosphorus‐31 NMR , 1987, American journal of clinical oncology.

[18]  B. Kruijff Polymorphic regulation of membrane lipid composition , 1987, Nature.

[19]  G. Batist,et al.  Differences in phosphate metabolite levels in drug-sensitive and -resistant human breast cancer cell lines determined by 31P magnetic resonance spectroscopy. , 1986, Cancer research.

[20]  A. Alfieri,et al.  Potentiation of radiation effects on two murine tumors by lonidamine. , 1986, Cancer research.

[21]  T. Ng,et al.  NMR study of in vivo RIF-1 tumors. Analysis of perchloric acid extracts and identification of 1H, 31P and 13C resonances. , 1984, Biochimica et biophysica acta.

[22]  M. Bárány,et al.  Phosphorus-31 nuclear magnetic resonance of contractile systems. , 1982, Methods in enzymology.

[23]  A. Verkleij,et al.  Lipidic intramembranous particles. , 1984, Nature.

[24]  A. Alfieri,et al.  An in situ method for estimating cell survival in a solid tumor. , 1978, Cancer research.

[25]  J. R. Wazer,et al.  Aqueous tetrahydroxyphosphonium perchlorate as a narrow-line 31P NMR reference substance , 1974 .